Does LETROZOLE\RIBOCICLIB Cause Tumour marker increased? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Tumour marker increased have been filed in association with LETROZOLE\RIBOCICLIB. This represents 1.3% of all adverse event reports for LETROZOLE\RIBOCICLIB.
8
Reports of Tumour marker increased with LETROZOLE\RIBOCICLIB
1.3%
of all LETROZOLE\RIBOCICLIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Tumour marker increased From LETROZOLE\RIBOCICLIB?
Of the 8 reports.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE\RIBOCICLIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE\RIBOCICLIB Cause?
Fatigue (69)
Death (66)
Nausea (57)
White blood cell count decreased (39)
Diarrhoea (35)
Rash (27)
Alopecia (25)
Neoplasm malignant (25)
Malaise (24)
Cough (22)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which LETROZOLE\RIBOCICLIB Alternatives Have Lower Tumour marker increased Risk?
LETROZOLE\RIBOCICLIB vs LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUCOVORIN\LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUPROLIDE
LETROZOLE\RIBOCICLIB vs LEVALBUTEROL
LETROZOLE\RIBOCICLIB vs LEVAMISOLE